Nexium (Esomeprazole Magnesium Trihydrate)

Nexium (esomeprazole magnesium trihydrate) is a proton pump inhibitor used to manage disorders related to excess gastric acid, improving symptom control and supporting mucosal healing.

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation.
• Erosive esophagitis: facilitates mucosal healing and reduces further acid damage.
• NSAID‑induced gastric ulcer: helps prevent ulcer formation and supports ulcer healing.
• Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by reducing gastric acidity.

• Esomeprazole magnesium trihydrate selectively and irreversibly binds to the sulfhydryl group of the H+/K+ ATPase enzyme (the gastric proton pump) located on the luminal surface of parietal cells. By inhibiting this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, leading to an increased gastric pH. The effect persists for up to 72 hours, allowing once‑daily dosing in most therapeutic regimens.

Common and serious adverse reactions have been reported with esomeprazole use; most are mild, transient, and resolve after discontinuation, while a few may be severe and require prompt medical evaluation. Patients should be advised to report any unexpected symptoms to their healthcare provider.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: loose stools, usually transient.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis associated with altered gut flora.
• Acute interstitial nephritis: inflammation of kidney interstitium.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Liver enzyme elevation: significant increase in ALT/AST levels.

Before prescribing esomeprazole, clinicians should consider several precautionary measures to ensure safe use.

• Assess renal function: dose adjustment may be needed in severe impairment.
• Evaluate for history of hypersensitivity: avoid use in patients with known allergy to PPIs.
• Monitor long‑term use: prolonged therapy may increase risk of bone fracture or vitamin B12 deficiency.
• Use with caution in elderly: higher incidence of adverse effects observed.
• Review concomitant antiretroviral therapy: some agents may reduce esomeprazole effectiveness.
• Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Esomeprazole may interact with several medicines; understanding the interaction potential helps optimize therapy.

Major Interactions (Avoid)

• Clopidogrel: concurrent use can diminish clopidogrel’s antiplatelet activation, potentially raising the risk of thrombotic events.
• Atazanavir: esomeprazole raises gastric pH, markedly reducing atazanavir absorption and compromising HIV treatment efficacy.
• Dasatinib: acid suppression may lower dasatinib plasma concentrations, leading to suboptimal control of chronic myeloid leukemia.

Moderate Interactions (Monitor Closely)

• Warfarin: proton pump inhibition can enhance warfarin’s anticoagulant effect, so INR should be checked more frequently.
• Methotrexate: reduced renal clearance may cause higher methotrexate exposure, increasing the chance of toxicity.
• Digoxin: modest increase in digoxin levels may occur; clinical monitoring for signs of digoxin toxicity is advised.